Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE



Provided by: Medscape

New SLE Guideline Aims to Improve Diagnosis, Reduce Steroids

Published: Tue, 17 Oct 2017 08:26:29 EDT
The British Society for Rheumatology issued the first comprehensive guideline for management of systemic lupus erythematosus in adults.
Medscape Medical News

EHR Work Measures Proposed to Address Burnout

Published: Tue, 17 Oct 2017 08:16:06 EDT
Commentary in Annals of Internal Medicine suggests vendors imbed metrics to measure extra work created by EHRs.
Medscape Medical News

Weight Watchers Successful Part of Diabetes Prevention in UK

Published: Tue, 17 Oct 2017 07:39:07 EDT
A diabetes prevention program delivered in association with Weight Watchers in the UK led to a marked average weight reduction (10 kg) and a significant fall in HbA1c in people with prediabetes.
Medscape Medical News

'Alarming' Increase in Stroke Risk Factors

Published: Tue, 17 Oct 2017 07:16:50 EDT
Despite many prevention initiatives, the prevalence of hypertension, diabetes, dyslipidemia, drug abuse, and smoking actually appears to be increasing among new ischemic stroke patients in the United States, a new study shows.
Medscape Medical News
Displaying results 13-16 (of 20)
 1 - 2 - 3 - 4 - 5 


Impact bags $22M to save ex-Sanofi drug from trial limbo

Published: Fri, 13 Oct 2017 12:05:54 +0000
In 2013, Sanofi was running multiple clinical trials to establish fedratinib as the cornerstone of its oncology portfolio. Then, in the space of a week, the FDA ordered a clinical hold and Sanofi canned the JAK2 inhibitor. Now, members of the team who first developed fedratinib have brought it back from the dead.

Spark Therapeutics’ Luxturna advisory committee vote sets gene therapy landmark

Published: Fri, 13 Oct 2017 10:18:34 +0000
After decades of research, a gene therapy to correct a specific genetic mutation is on the brink of being approved by the FDA.

New stem cell type expands R&D, regenerative medicine possibilities

Published: Thu, 12 Oct 2017 14:00:13 +0000
Scientists from the Wellcome Trust Sanger Institute have created a new type of stem cell that retains the ability to develop into any type of cell. Derived from embryos in the earliest stage of development, these stem cells open the doors to disease research and the development of regenerative treatments.

AcelRx crushed, again, after FDA knocks back pain drug

Published: Thu, 12 Oct 2017 13:30:26 +0000
AcelRx Pharmaceuticals is in the doghouse with investors yet again. The latest, 60% hit to AcelRx’s stock price followed another run-in with the FDA, which knocked back a filing for approval of pain drug Dsuvia.
Displaying results 13-16 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy